BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

990 related articles for article (PubMed ID: 29494606)

  • 21. Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
    Evans DS; Alphonsus K; Umaru J; Eigege A; Miri E; Mafuyai H; Gonzales-Peralta C; Adamani W; Pede E; Umbugadu C; Saka Y; Okoeguale B; Richards FO
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3113. PubMed ID: 25233351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone.
    Richards F; Rizzo N; Diaz Espinoza CE; Monroy ZM; Crovella Valdez CG; de Cabrera RM; de Leon O; Zea-Flores G; Sauerbrey M; Morales AL; Rios D; Unnasch TR; Hassan HK; Klein R; Eberhard M; Cupp E; Domínguez A
    Am J Trop Med Hyg; 2015 Dec; 93(6):1295-304. PubMed ID: 26503275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onchocerca ochengi: assessment of the Simulium vectors in north Cameroon.
    Wahl G; Ekale D; Schmitz A
    Parasitology; 1998 Apr; 116 ( Pt 4)():327-36. PubMed ID: 9585935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
    Lovato R; Guevara A; Guderian R; Proaño R; Unnasch T; Criollo H; Hassan HK; Mackenzie CD
    PLoS Negl Trop Dis; 2014 May; 8(5):e2821. PubMed ID: 24853587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
    Guevara Á; Lovato R; Proaño R; Rodriguez-Perez MA; Unnasch T; Cooper PJ; Guderian RH
    Parasit Vectors; 2018 Apr; 11(1):265. PubMed ID: 29690907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.
    Golden A; Faulx D; Kalnoky M; Stevens E; Yokobe L; Peck R; Karabou P; Banla M; Rao R; Adade K; Gantin RG; Komlan K; Soboslay PT; de Los Santos T; Domingo GJ
    Parasit Vectors; 2016 Jun; 9(1):338. PubMed ID: 27296630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
    Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR
    PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population biology of human onchocerciasis.
    Basáñez MG; Boussinesq M
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Onchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex.
    Lamberton PH; Cheke RA; Walker M; Winskill P; Crainey JL; Boakye DA; Osei-Atweneboana MY; Tirados I; Wilson MD; Tetteh-Kumah A; Otoo S; Post RJ; Basañez MG
    Parasit Vectors; 2016 Aug; 9(1):432. PubMed ID: 27494934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onchocerciasis in Gilgel Ghibe River Valley southwest Ethiopia.
    Taye A; Gebre-Michael T; Taticheff S
    East Afr Med J; 2000 Feb; 77(2):116-20. PubMed ID: 10774086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus.
    Botto C; Basañez MG; Escalona M; Villamizar NJ; Noya-Alarcón O; Cortez J; Vivas-Martínez S; Coronel P; Frontado H; Flores J; Graterol B; Camacho O; Tovar Y; Borges D; Morales AL; Ríos D; Guerra F; Margeli H; Rodriguez MA; Unnasch TR; Grillet ME
    Parasit Vectors; 2016 Jan; 9():40. PubMed ID: 26813296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
    Adewale B; Oyerinde JP; Mafe MA
    West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vector-parasite transmission complexes for onchocerciasis in West Africa.
    Toé L; Tang J; Back C; Katholi CR; Unnasch TR
    Lancet; 1997 Jan; 349(9046):163-6. PubMed ID: 9111540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda.
    Jacob BG; Loum D; Lakwo TL; Katholi CR; Habomugisha P; Byamukama E; Tukahebwa E; Cupp EW; Unnasch TR
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006702. PubMed ID: 30148838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taking the strain out of onchocerciasis? A reanalysis of blindness and transmission data does not support the existence of a savannah blinding strain of onchocerciasis in West Africa.
    Cheke RA; Little KE; Young S; Walker M; Basáñez MG
    Adv Parasitol; 2021; 112():1-50. PubMed ID: 34024357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
    Katabarwa MN; Eyamba A; Nwane P; Enyong P; Yaya S; Baldiagaï J; Madi TK; Yougouda A; Andze GO; Richards FO
    Am J Trop Med Hyg; 2011 Dec; 85(6):1041-9. PubMed ID: 22144441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.
    Katabarwa MN; Zarroug IMA; Negussu N; Aziz NM; Tadesse Z; Elmubark WA; Shumo Z; Meribo K; Kamal H; Mohammed A; Bitew Y; Seid T; Bekele F; Yilak A; Endeshaw T; Hassen M; Tillahun A; Samuel F; Birhanu H; Asmare T; Boakye D; Feleke SM; Unnasch T; Post R; Higazi T; Griswold E; Mackenzie C; Richards F
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007830. PubMed ID: 32027648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.